Eikonizo Therapeutics

Cambridge, United States

Eikonizo Therapeutics is a biopharmaceutical company.

Oct 2025

Grant

Biotechnology Health Care Pharmaceutical

Top Investors

Novo Nordisk National Institute of Neurological Disorders and Stroke

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Eikonizo Therapeutics

Who are Eikonizo Therapeutics's investors?

Eikonizo Therapeutics's investors include Novo Nordisk, National Institute of Neurological Disorders and Stroke.

Where is Eikonizo Therapeutics headquartered?

Eikonizo Therapeutics is headquartered in Cambridge, United States.

What does Eikonizo Therapeutics do?

Eikonizo Therapeutics is a biopharmaceutical company.

What stage is Eikonizo Therapeutics at?

Eikonizo Therapeutics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 9, 2025.

MLA

"Eikonizo Therapeutics — Funding & Investors." VCBacked, October 9, 2025, https://www.vcbacked.co/company/eikonizo-therapeutics. Accessed July 3, 2026.

APA

VCBacked. (2025). Eikonizo Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/eikonizo-therapeutics

Wikipedia (cite web)

{{cite web |title=Eikonizo Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/eikonizo-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 9, 2025.